Norris Perne & French’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,454
Closed -$249K 128
2018
Q3
$249K Buy
+1,454
New +$249K 0.03% 123